DNA evidence and technology could yield new leads in the decade-old unsolved murders of a wealthy Lake Oconee couple, ...

In addition to the At-Home Cellular System, LifeFone offers mobile devices, a smartwatch and a base unit that uses a landline ...

How cancer cells tug against each other determines whether they can migrate elsewhere in the body. Understanding how cancerous cells spread from a primary tumor is important for any number of reasons, ...

The surging popularity of eSIMs could allow Apple to launch its own virtual cellular network, an analyst firm predicts ...

Apple at its "Let Loose" event today announced new iPad Pro and iPad Air models, and there are smaller changes compared to the ...

Intra-Cellular Therapies presents Q1 figures on May 7. Analysts are expecting losses per share of $0.317. Watch Intra-Cellular Therapies stock price move in real-time ahead here. Intra-Cellular ...

Cellular IoT Module Market is projected to reach approximately US$ 20.83 Billion, to augment at a CAGR of 23.4% during ...

ITCI stock results show that Intra-Cellular Therapies beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.More From InvestorPlace The #1 AI Investment Might ...

“We continued to deliver strong growth for CAPLYTA in the first quarter,” said Dr. Sharon Mates, Chairman and CEO of Intra-Cellular Therapies. “We also achieved a significant milestone in our ...

In product listings for the new devices, Apple confirmed that the new iPad Air and Pro cellular models will not include a physical SIM card tray.

NEW YORK (AP) — NEW YORK (AP) — Intra-Cellular Therapies Inc. (ITCI) on Tuesday reported a loss of $15.2 million in its first quarter. On a per-share basis, the New York-based company said it had a ...

An article published in The FASEB Journal describes a Brazilian study analyzing the correlation between two key energy ...